Conduct a Trial Stimulation Period Before Implanting a Spinal Cord Stimulator (SCS) - Letter to Health Care Providers | FDA

Conduct a Trial Stimulation Period Before Implanting a Spinal Cord Stimulator (SCS) - Letter to Health Care Providers | FDA

Conduct a Trial Stimulation Period Before Implanting a Spinal Cord Stimulator (SCS): Letter to Health Care Providers

Today, the U.S. Food and Drug Administration (FDA) is reminding health care providers of the importance of conducting a trial stimulation period to allow patients to confirm satisfactory pain relief before implanting a spinal cord stimulator (SCS).

Read the Letter to Health Care Providers The Letter to Health Care Providers includes important information about SCS, including: Recommendations for health care providers to consider before SCS implantation. Recommended topics for patient-doctor communication. Actions the FDA has taken to evaluate information included in SCS medical device reports. Instructions for reporting problems with a SCS device. Questions? If you have questions about this Letter to Health Care Providers, contact the Division of Industry and Consumer Education (DICE).